Medication info
Berkub Tablet 10 mg (Vericiguat (uncoated))

Berkub Tablet 10 mg (Vericiguat (uncoated))

Prescription medicationTabletOral
Ingredient · strength
Vericiguat Micronized›10mg / 1 tablet
Manufacturer / importer
Bayer korea
Appearance
Biconvex round film-coated tablet in yellow-orange color
Packaging
Domestic - 28 tablets/box [(14 tablets/blister x 2)]
Approval status
Active

MFDS item code 202107709 · Approved 2021.11.30 · Insurance code 641106170

Summary

Main use
Reduction of the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure
Who takes it
Adults
Adult dose
1. Adults The recommended starting dose of this medicine is 2.5mg once daily. Take with food. Depending on the patient's tolerability, double the dose approximately every 2 weeks until the target maintenance dose of 10mg once daily is reached. If the patient does not tolerate the medicine well (systolic blood pressure below 90 mmHg or symptomatic hypotension), reduce the dose or discontinue treatment. Do not initiate treatment with this medicine if systolic blood pressure is below 100 mmHg. For patients unable to swallow the tablet whole, this medicine may be crushed and mixed with water immediately before taking it. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information) Missed dose: If a dose is missed, take it as soon as possible on the same day. Do not take this medicine twice on the same day. 2. Older adults No dose adjustment is necessary in older adults. (See 9. Use in older adults and 11. Information for healthcare professionals, 2) Pharmacokinetic information) 3. Patients with renal impairment No dose adjustment is necessary in patients with eGFR≥15mL/min/1.73m2 who are not receiving dialysis. This medicine has not been studied in patients with eGFR<15 mL/min/1.73m2 or in patients receiving dialysis at treatment initiation; therefore, it is not recommended for these patients. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information) 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. This medicine has not been studied in patients with severe hepatic impairment; therefore, it is not recommended for these patients. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information)

Ingredients

Importer
Bayer korea

Efficacy & effects

Reduction of the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure

  • Chronic heart failure
  • reduced left ventricular ejection fraction
  • symptomatic chronic heart failure
View approved original text

This medication helps reduce the risk of death from cardiovascular disease and the risk of hospitalization due to heart failure in symptomatic chronic heart failure patients with a left ventricular ejection fraction of less than 45%. It is particularly effective in patients who have recently been hospitalized for heart failure or are using intravenous diuretics. This medication is used in conjunction with other heart failure treatments to enhance therapeutic effects, thus playing an important role in managing heart failure and improving the patient's health condition.

How to take

Adult dose

1. Adults The recommended starting dose of this medicine is 2.5mg once daily. Take with food. Depending on the patient's tolerability, double the dose approximately every 2 weeks until the target maintenance dose of 10mg once daily is reached. If the patient does not tolerate the medicine well (systolic blood pressure below 90 mmHg or symptomatic hypotension), reduce the dose or discontinue treatment. Do not initiate treatment with this medicine if systolic blood pressure is below 100 mmHg. For patients unable to swallow the tablet whole, this medicine may be crushed and mixed with water immediately before taking it. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information) Missed dose: If a dose is missed, take it as soon as possible on the same day. Do not take this medicine twice on the same day. 2. Older adults No dose adjustment is necessary in older adults. (See 9. Use in older adults and 11. Information for healthcare professionals, 2) Pharmacokinetic information) 3. Patients with renal impairment No dose adjustment is necessary in patients with eGFR≥15mL/min/1.73m2 who are not receiving dialysis. This medicine has not been studied in patients with eGFR<15 mL/min/1.73m2 or in patients receiving dialysis at treatment initiation; therefore, it is not recommended for these patients. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information) 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. This medicine has not been studied in patients with severe hepatic impairment; therefore, it is not recommended for these patients. (See 11. Information for healthcare professionals, 2) Pharmacokinetic information)

Precautions

This medication must not be administered to pregnant women as it may harm the fetus. Women of childbearing potential must confirm pregnancy before taking this medication, and during treatment and for one month after discontinuation, effective contraception must be used to prevent pregnancy. Patients with an allergy to any component of this medication, those who are taking specific other medications, and patients with genetic lactose-related disorders should not use this medication. Patients with low blood pressure or symptomatic hypotension should exercise particular caution when using this medication, and if blood pressure is very low, the dose may need to be reduced or administration stopped. It is not recommended to use this medication in patients with weak heart function in conjunction with certain other cardiac medications (e.g., PDE-5 inhibitors or long-acting nitrate preparations). Administration of this medication is not recommended in patients with severely impaired kidney function or those on dialysis, as well as in patients with severe liver disease. This medication may cause side effects such as dizziness, headache, nausea, vomiting, dyspepsia, gastroesophageal reflux disease, hypotension, and anemia, so if any unusual symptoms occur, immediate consultation with healthcare providers is necessary. This medication may cause symptomatic hypotension, thus patients with low blood pressure or a history of hypotension should be especially cautious. There are medications that cannot be used in conjunction with this one; therefore, if taking other medications, be sure to consult a professional. Pregnant or breastfeeding women should not take this medication, and if breastfeeding, they should stop nursing while taking this medication. In children, safety and efficacy have not been established, so its use is not recommended. Elderly patients can use this medication without special dose adjustments, but caution is required as some elderly patients may be more sensitive to side effects. In case of overdose, hypotension may occur; therefore, if an overdose is suspected, visit a medical institution immediately for appropriate treatment.

Side effects

  • Anemia
  • nausea
  • dyspepsia
  • vomiting
  • gastroesophageal reflux disease
  • dizziness
  • headache
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at a cool temperature between 2 to 30 degrees Celsius to maintain the drug's efficacy.

Appearance and packaging

Appearance

Biconvex round film-coated tablet in yellow-orange color

Package unit

Domestic - 28 tablets/box [(14 tablets/blister x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.